Report cover image

North America Oncology Market Databank

Publisher Magna Intelligence
Published Apr 01, 2022
Length 85 Pages
SKU # MAIN17867169

Description

North America Oncology Market Databank

The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Cancer treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated to reach $201,161.7 Million by 2029 with the highest CAGR of 4.43%.

The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.

Table of Contents

85 Pages
1. GLOBAL ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
1.1. OVERVIEW
1.2. CANCER DIAGNOSTICS
1.2.1 CANCER DIAGNOSTICS MARKET, BY REGION
1.2.1.1 North America Cancer diagnostics Market, By Country
1.2.1.2 Europe Cancer diagnostics Market, By Country
1.2.1.3 Asia-Pacific Cancer diagnostics Market, By Country
1.2.1.4 Rest of World Cancer diagnostics Market, By Country
1.3. CANCER TREATMENT
1.3.1 CANCER TREATMENT MARKET, BY REGION
1.3.1.1 North America Cancer treatment Market, By Country
1.3.1.2 Europe Cancer treatment Market, By Country
1.3.1.3 Asia-Pacific Cancer treatment Market, By Country
1.3.1.4 Rest of World Cancer treatment Market, By Country
2. GLOBAL ONCOLOGY MARKET, BY CANCER TYPE
2.1. OVERVIEW
2.2. LUNG CANCER
2.2.1 LUNG CANCER MARKET, BY REGION
2.2.1.1 North America Lung cancer Market, By Country
2.2.1.2 Europe Lung cancer Market, By Country
2.2.1.3 Asia-Pacific Lung cancer Market, By Country
2.2.1.4 Rest of World Lung cancer Market, By Country
2.3. PROSTATE CANCER
2.3.1 PROSTATE CANCER MARKET, BY REGION
2.3.1.1 North America Prostate cancer Market, By Country
2.3.1.2 Europe Prostate cancer Market, By Country
2.3.1.3 Asia-Pacific Prostate cancer Market, By Country
2.3.1.4 Rest of World Prostate cancer Market, By Country
2.4. COLON & RECTAL CANCER
2.4.1 COLON & RECTAL CANCER MARKET, BY REGION
2.4.1.1 North America Colon & rectal cancer Market, By Country
2.4.1.2 Europe Colon & rectal cancer Market, By Country
2.4.1.3 Asia-Pacific Colon & rectal cancer Market, By Country
2.4.1.4 Rest of World Colon & rectal cancer Market, By Country
2.5. LIVER CANCER
2.5.1 LIVER CANCER MARKET, BY REGION
2.5.1.1 North America Liver cancer Market, By Country
2.5.1.2 Europe Liver cancer Market, By Country
2.5.1.3 Asia-Pacific Liver cancer Market, By Country
2.5.1.4 Rest of World Liver cancer Market, By Country
2.6. BREAST CANCER
2.6.1 BREAST CANCER MARKET, BY REGION
2.6.1.1 North America Breast cancer Market, By Country
2.6.1.2 Europe Breast cancer Market, By Country
2.6.1.3 Asia-Pacific Breast cancer Market, By Country
2.6.1.4 Rest of World Breast cancer Market, By Country
2.7. OTHER CANCER TYPES
2.7.1 OTHER CANCER TYPES MARKET, BY REGION
2.7.1.1 North America Other Cancer Types Market, By Country
2.7.1.2 Europe Other Cancer Types Market, By Country
2.7.1.3 Asia-Pacific Other Cancer Types Market, By Country
2.7.1.4 Rest of World Other Cancer Types Market, By Country
3. GLOBAL ONCOLOGY MARKET, BY REGION
3.1. OVERVIEW
3.2. NORTH AMERICA
3.2.1 NORTH AMERICA ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
3.2.2 NORTH AMERICA ONCOLOGY MARKET, BY CANCER TYPE
3.2.3 NORTH AMERICA ONCOLOGY MARKET, BY COUNTRY
3.2.3.1 U.S.
3.2.3.1.1 U.S. Oncology Market, By By Cancer Diagnostics & Treatment
3.2.3.1.2 U.S. Oncology Market, By Cancer Type
3.2.3.2 Canada
3.2.3.2.1 Canada Oncology Market, By By Cancer Diagnostics & Treatment
3.2.3.2.2 Canada Oncology Market, By Cancer Type
3.2.3.3 Mexico
3.2.3.3.1 Mexico Oncology Market, By By Cancer Diagnostics & Treatment
3.2.3.3.2 Mexico Oncology Market, By Cancer Type
TABLE 1. GLOBAL ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 2. CANCER DIAGNOSTICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 3. NORTH AMERICA CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 4. EUROPE CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 5. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 6. REST OF WORLD CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 7. CANCER TREATMENT MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 8. NORTH AMERICA CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 9. EUROPE CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 10. ASIA-PACIFIC CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 11. REST OF WORLD CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 12. GLOBAL ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 13. LUNG CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 14. NORTH AMERICA LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 15. EUROPE LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 16. ASIA-PACIFIC LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 17. REST OF WORLD LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 18. PROSTATE CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 19. NORTH AMERICA PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 20. EUROPE PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 21. ASIA-PACIFIC PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 22. REST OF WORLD PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 23. COLON & RECTAL CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 24. NORTH AMERICA COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 25. EUROPE COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 26. ASIA-PACIFIC COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 27. REST OF WORLD COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 28. LIVER CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 29. NORTH AMERICA LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 30. EUROPE LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 31. ASIA-PACIFIC LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 32. REST OF WORLD LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 33. BREAST CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 34. NORTH AMERICA BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 35. EUROPE BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 36. ASIA-PACIFIC BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 37. REST OF WORLD BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 38. OTHER CANCER TYPES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 39. NORTH AMERICA OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 40. EUROPE OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 41. ASIA-PACIFIC OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 42. REST OF WORLD OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 43. GLOBAL ONCOLOGY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 44. NORTH AMERICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 45. NORTH AMERICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 46. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 47. U.S. ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 48. U.S. ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 49. CANADA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 50. CANADA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 51. MEXICO ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 52. MEXICO ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 53. ROW COUNTRIES ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 1. GLOBAL ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 2. CANCER DIAGNOSTICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 3. NORTH AMERICA CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 4. EUROPE CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 5. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 6. REST OF WORLD CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 7. CANCER TREATMENT MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 8. NORTH AMERICA CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 9. EUROPE CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 10. ASIA-PACIFIC CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 11. REST OF WORLD CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 12. GLOBAL ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 13. LUNG CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 14. NORTH AMERICA LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 15. EUROPE LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 16. ASIA-PACIFIC LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 17. REST OF WORLD LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 18. PROSTATE CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 19. NORTH AMERICA PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 20. EUROPE PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 21. ASIA-PACIFIC PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 22. REST OF WORLD PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 23. COLON & RECTAL CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 24. NORTH AMERICA COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 25. EUROPE COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 26. ASIA-PACIFIC COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 27. REST OF WORLD COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 28. LIVER CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 29. NORTH AMERICA LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 30. EUROPE LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 31. ASIA-PACIFIC LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 32. REST OF WORLD LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 33. BREAST CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 34. NORTH AMERICA BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 35. EUROPE BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 36. ASIA-PACIFIC BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 37. REST OF WORLD BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 38. OTHER CANCER TYPES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 39. NORTH AMERICA OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 40. EUROPE OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 41. ASIA-PACIFIC OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 42. REST OF WORLD OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 43. GLOBAL ONCOLOGY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 44. NORTH AMERICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 45. NORTH AMERICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 46. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 47. U.S. ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 48. U.S. ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 49. CANADA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 50. CANADA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 51. MEXICO ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 52. MEXICO ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 53. ROW COUNTRIES ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us